OQS
RXST icon

Occudo Quantitative Strategies’s RxSight RXST Stock Holding History

Occudo Quantitative Strategies’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,616
Closed -$398K – 990
2024
Q2 		$398K Sell
6,616
-3,203
-33% -$183K 0.07% 361
2024
Q1 		$506K Sell
9,819
-21,609
-69% -$1.06M 0.09% 301
2023
Q4 		$1.27M Buy
+31,428
New +$922K 0.17% 163
2023
Q3 		– Sell
-17,544
Closed -$505K – 1273
2023
Q2 		$505K Buy
+17,544
New +$390K 0.05% 555

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's RXST Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of RxSight (RXST) in Q3 2024, closing a stake of 6,616 shares — an estimated $398K sold.

Occudo Quantitative Strategies first reported a position in RXST in Q2 2023 and held it in 4 quarters. The position peaked at $1.27M in Q4 2023. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Occudo Quantitative Strategies reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,616 RxSight shares in Q3 2024, an estimated $398K.
  • Occudo Quantitative Strategies first reported a position in RxSight in Q2 2023 and held it in 4 quarters.
  • Occudo Quantitative Strategies's RxSight position peaked at $1.27M in Q4 2023.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.